FMP
Lexaria Bioscience Corp.
LEXX
NASDAQ
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
1.24 USD
-0.115 (-9.31%)
About
ceo
Mr. Richard C. Christopher
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectively across the blood brain barrier. It operates a licensed in-house research laboratory and holds intellectual property portfolio with 23 patents granted and approximately 50 patents pending worldwide. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
CIK
0001348362
ISIN
US52886N4060
CUSIP
52886N406
Address
100 – 740 McCurdy Road
Phone
250 765 6424
Country
CA
Employee
7
IPO Date
Jan 12, 2021
Key Executives
Name
Title
Pay
Year Born
Mr. Richard C. Christopher
Chief Executive Officer & Director
5k
1970
Mr. John M. Docherty M.Sc.
Chairman of the Scientific Advisory Boar...
329.34k
1969
Vanessa Carle
Head of Legal
0
N/A
Dr. C. Michael Gibson M.D., M.S.
Chief Medical Advisor & Member of Scient...
0
N/A
Mr. Michael Shankman CPA
Chief Financial Officer
0
1960
Ms. Kristin Hamilton
Director of Operations
0
N/A
As of December 31, 2024, the total employee count stands at 7, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.
